scout

Annamaria Molino, MD

Articles by Annamaria Molino, MD

Gemcitabine/Epirubicin/Paclitaxel Trials in Advanced Breast Cancer

ByPierfranco Conte, MD,Barbara Salvadori, MD,Sara Donati, MD,Alessandra Gennari, MD,Gian Luigi Cetto, MD,Annamaria Molino, MD,Lucio CrinÒ, MD,Francesca Mazzoni, MD,Enzo Galligioni, MD,Maurizio Mansutti, MD

Numerous trials have shown that the pharmacokinetic interferences of epirubicin (Ellence)/paclitaxel (Taxol) combinations produce less pharmacodynamic effect than doxorubicin/paclitaxel regimens. Paclitaxel is more easily

Latest Updated Articles